H2AX and breast carcinoma: This allows ATM to phosphorylate S139 of H2AX (γH2AX) and promote H2AX-binding with a mediator of DNA damage checkpoint 1 (MDC1) via the breast cancer-associated C-terminal domain as shown via X-ray diffraction [136,137] (Figure 9B).